Certified by Founder Lodge
Ablaze Pharmaceuticals
China - Shanghai
START UP
1 Disclosed Funding Rounds $75,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ablaze Pharma is a clinical stage Biopharmaceutical Company which is focused on the developing innovative Targeted Radiotherapy (TRT) to benefit cancer patients in China.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 29 ,2021 | Series A | $75,000,000 |
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Allos | $5,000,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
